SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

Share Price is delayed by 15 minutes
Get Live Data
1.60    0.05 (3.23%)
Bid:
1.60
Ask:
2.00
Spread: 0.40 (25.00%)
Market Cap: £5.61m
PRM Live PriceLast checked at - London Stock Exchange

Intraday Proteome Share Chart

Proteome Hails "Encouraging" Interim Progress As Loss Improves

Thu, 25th Jul 2019 12:33

(Alliance News) - Life sciences firm Proteome Sciences PLC said Thursday momentum continued to build in the first half of 2019, with losses improving after revenue jumped and costs fell.

For the six months ended June, the pretax loss improved to GBP410,000 from GBP1.4 million the year prior. This was after revenue rose 31% to GBP1.7 million from GBP1.3 million the year before.

Profit performance was helped by a sharp fall in administrative costs to GBP1.2 million from GBP2.0 million the year prior.

"Performance during the first six months of 2019 was very encouraging, building on the momentum developed in the second half of 2018," Chief Executive Jeremy Haigh said.

"Recognised revenues from our services platform were significantly ahead of the equivalent period in 2018 and, most importantly, we issued a record number of quotes for new business in the second quarter, a fundamental lead indicator of future customer engagement," Haigh added.

Services revenue surged 30% to GBP350,000 from GBP270,000 the year prior.

"Administrative costs continue to reduce, and cash reserves are stronger; as a consequence, the company is beginning to demonstrate a much-anticipated level of fiscal stability and growth which should enable some near-term investment that will be vital if we are to remain competitive in such a rapidly developing market," Haigh continued.

"We are confident that our commercial strategy is starting to gain traction after a slow start early in 2018 and, with the promise of a stronger second half which has been characteristic of previous years, we expect to report further progress", Haigh concluded.

Shares in Proteome were 4.7% lower at 3.58 pence in London on Thursday.

Related News

WINNERS & LOSERS: Aeorema wins climate event deal; RWS cuts dividend
4 days ago

WINNERS & LOSERS: Aeorema wins climate event deal; RWS cuts dividend

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.

EXECUTIVE CHANGES: Victoria doesn't replace CEO; all change at eEnergy
5 Jun 2026

EXECUTIVE CHANGES: Victoria doesn't replace CEO; all change at eEnergy

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced this week and not separately reported by...

WINNERS & LOSERS: Marechale rallies on digital bank plan; boohoo jumps
3 Jun 2026

WINNERS & LOSERS: Marechale rallies on digital bank plan; boohoo jumps

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday.

Proteome News

WINNERS & LOSERS: Aeorema wins climate event deal; RWS cuts dividend
4 days ago

WINNERS & LOSERS: Aeorema wins climate event deal; RWS cuts dividend

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.

EXECUTIVE CHANGES: Victoria doesn't replace CEO; all change at eEnergy
5 Jun 2026

EXECUTIVE CHANGES: Victoria doesn't replace CEO; all change at eEnergy

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced this week and not separately reported by...

WINNERS & LOSERS: Marechale rallies on digital bank plan; boohoo jumps
3 Jun 2026

WINNERS & LOSERS: Marechale rallies on digital bank plan; boohoo jumps

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday.

WINNERS & LOSERS: Gelion agrees to collaboration; Sabien receives fees
2 Jun 2026

WINNERS & LOSERS: Gelion agrees to collaboration; Sabien receives fees

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.

WINNERS & LOSERS: GSTechnologies wins ruling; RentGuarantor revenue up
1 Jun 2026

WINNERS & LOSERS: GSTechnologies wins ruling; RentGuarantor revenue up

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday.

WINNERS & LOSERS: Hamak jumps on gold data; MicroSalt cuts sales guide
28 May 2026

WINNERS & LOSERS: Hamak jumps on gold data; MicroSalt cuts sales guide

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.

WINNERS & LOSERS: Indonesia curbs hit MP Evans; S&U rises
20 May 2026

WINNERS & LOSERS: Indonesia curbs hit MP Evans; S&U rises

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday.

WINNERS & LOSERS: Advanced Medical suitor walks away; Capita climbs
18 May 2026

WINNERS & LOSERS: Advanced Medical suitor walks away; Capita climbs

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday.